Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study.
about
Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression.Efficacy of ketamine in the rapid treatment of major depressive disorder: a meta-analysis of randomized, double-blind, placebo-controlled studies.Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories.Targeting glutamate signalling in depression: progress and prospects.Pharmacotherapy of major depression in late life: what is the role of new agents?Effects of intravenous ketamine in a patient with post-treatment Lyme disease syndrome.The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis.Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial.Dose-Related Effects of Adjunctive Ketamine in Taiwanese Patients with Treatment-Resistant Depression.Clinical Factor 2016.Convergent Mechanisms Underlying Rapid Antidepressant Action.A review of ketamine's role in ECT and non-ECT settings.Addictive potential of novel treatments for refractory depression and anxiety.Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.Effect of low-dose ketamine on PerioperAtive depreSsive Symptoms in patients undergoing Intracranial tumOr resectioN (PASSION): study protocol for a randomized controlled trialEradicating Suicide at Its Roots: Preclinical Bases and Clinical Evidence of the Efficacy of Ketamine in the Treatment of Suicidal Behaviors
P2860
Q34551188-3E96E097-7C97-4ADF-85FB-6799988C0AE1Q37398383-4F0DEE30-0C51-45A2-8D0E-3CA8FE6D8BF1Q37424333-E1B1DAAF-7424-4A3E-A85D-342892609EE3Q38743867-919B9000-D0E2-40CB-AA6D-C5BAD2D6DF8BQ38894956-697DAEDF-A5A0-43F8-811B-674F23FDD53CQ39150475-BEAABC62-AC62-4493-9888-89770071F3EBQ47402907-68120D04-B5DB-4A02-A848-788AEC7D2987Q47688167-A055B18B-A6EE-4551-A133-68CF6C761496Q47890256-D52D84F4-C94C-4509-964F-9A6B74755341Q50050380-E517393D-1C5F-483C-8180-FC0A9F95422EQ52667723-77193371-01D5-4BC9-A0F7-331223FB2392Q55185849-E56BEFD9-B918-4610-B6B5-4D3989A6F971Q55334438-A8A57275-A724-4727-A991-06062AABD599Q55438088-1DFF2570-46D2-457A-A5F5-00B28379C6B9Q58696620-3FB62B7C-DD49-4315-B371-B0BC80A3365AQ59138279-69ACCB0C-08BB-450A-9652-BE9BF4DD7072
P2860
Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Single i.v. ketamine augmentat ...... acebo-controlled 4-week study.
@en
Single i.v. ketamine augmentat ...... acebo-controlled 4-week study.
@nl
type
label
Single i.v. ketamine augmentat ...... acebo-controlled 4-week study.
@en
Single i.v. ketamine augmentat ...... acebo-controlled 4-week study.
@nl
prefLabel
Single i.v. ketamine augmentat ...... acebo-controlled 4-week study.
@en
Single i.v. ketamine augmentat ...... acebo-controlled 4-week study.
@nl
P2093
P2860
P1476
Single i.v. ketamine augmentat ...... acebo-controlled 4-week study.
@en
P2093
C U Correll
G S Ungvari
H F K Chiu
P2860
P304
P356
10.1017/S0033291715002159
P407
P577
2015-10-19T00:00:00Z